Inventor · disambiguated record
Liqi He
Also filed as: HE LIQI
27 granted patents·11 pending applications·358 citations·filing 1997–2025
96Inventor score
Files withBRISTOL MYERS SQUIBB CO28DU PONT PHARM CO3BRISTOL MYERS SQUIBB PHARMA CO2FINK BRIAN E2MARKWALDER JAY A1
Top patents by PatentIndex Score
38 records- 0197US6191131B1Azolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1998·Granted Feb 20, 2001·107 cites·35 claims
- 0295US10487084B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Nov 26, 2019·16 cites·15 claims
- 0394US10508115B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 17, 2019·13 cites·19 claims
- 0494US10494370B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 3, 2019·15 cites·6 claims
- 0594US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0692US11400094B22H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 2, 2022·4 cites·18 claims
- 0792US6124289AAzolo triazines and pyrimidinesDU PONT PHARM CO·Filed 1997·Granted Sep 26, 2000·57 cites·21 claims
- 0891US6358950B1Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2000·Granted Mar 19, 2002·23 cites·8 claims
- 0989US8252795B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Aug 28, 2012·19 cites·11 claims
- 1086US11554120B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jan 17, 2023·4 cites·13 claims
- 1186US7678793B2Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB PHARMA CO·Filed 2006·Granted Mar 16, 2010·3 cites·4 claims
- 1279US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1379US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1477US10723736B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 28, 2020·0 cites·1 claims
- 1577US10711003B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 14, 2020·0 cites·1 claims
- 1677US8791257B2Substituted pyrrolotriazines as protein kinase inhibitorsMARKWALDER JAY A·Filed 2011·Granted Jul 29, 2014·6 cites·13 claims
- 1777US7923556B2Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 12, 2011·2 cites·10 claims
- 1877US6313124B1Tetrazine bicyclic compoundsDU PONT PHARM CO·Filed 1998·Granted Nov 6, 2001·53 cites·14 claims
- 1975US2023140047A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS AND METHODS AND USES THEREFORBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2074US10913741B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 9, 2021·0 cites·1 claims
- 2174US10689382B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 23, 2020·0 cites·1 claims
- 2273US10793569B2Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 6, 2020·0 cites·1 claims
- 2372US10927114B2Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 23, 2021·0 cites·1 claims
- 2472US10919895B2Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses thereforBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Feb 16, 2021·0 cites·1 claims
- 2561US7094782B1Azolo triazines and pyrimidinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 22, 2006·1 cites·1 claims
- 2657US9371328B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 21, 2016·0 cites·8 claims
- 2755US12485123B21H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Dec 2, 2025·0 cites·10 claims
- 2853US2023041738A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2953US2023122249A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3053US2023140430A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3153US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3252US2025282786A1Tricyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3352US2023144824A11H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTSBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 3451US2012283241A1Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2012·Application pending·0 cites
- 3549US11485741B2Macrocyclic toll-like receptor 7 (TLR7) agonistsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 1, 2022·0 cites·18 claims
- 3649US2006178388A1Phenyl-substituted pyrimidine compounds useful as kinase inhibitorsWROBLESKI STEPHEN T·Filed 2006·Application pending·0 cites
- 3745US2025282776A1Bicyclic TLR7 Agonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 3841US2003008885A1Azolo triazines and pyrimidinesFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liqi He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →